Tennessee's FairRx Act bans companies from owning both pharmacies and pharmacy benefit managers — a real structural separation targeting CVS's vertically integrated model that controls over 80% of the market. The bill passed overwhelmingly with bipartisan support and addresses documented unfair pricing practices, though CVS disputes that it will lower patient costs and is preparing a federal lawsuit similar to its Arkansas challenge. The post endorses the bill without noting this genuine dispute over patient impact or the uncertain legal future of similar state laws.